The Advanced Practice Registered Nurse as a Prescriber

3 Alabama State Board of Nursing. (2020). Nurse Practice Act Article 5, Advanced Practice Nursing §34‐21‐86. Retrieved from https://www.abn.alabama.gov/wp‐content/uploads/2016/02/nursing‐practice‐act‐article‐5.pdf. (Accessed 7 September 2020.)

4 Alex, S., Adenew, A.B., Arundel, C., et al. (2016). Medication errors despite using electronic health records: The value of a clinical pharmacist service in reducing discharge‐related medication errors. Quality Management in Health Care, 25(1), 32–37.

5 Blanco‐Reina, E., Arixza‐Zafra, G., Ocana‐Ricola, R., & Leon‐Ortiz, M. (2014). 2012 American Geriatrics Society Beers Criteria: Enhanced applicability for detecting potentially inappropriate medications in European older adults? A comparison with the Screening Tool of Older Person’s Potentially Inappropriate Prescriptions. Journal of the American Geriatric Society, 62(7), 1217–1223.

6 Brown, S.A., & Grimes, D.E. (1995). A meta‐analysis of nurse practitioners and nurse midwives in primary care. Nursing Research, 44(6), 332–339.

7 Brown, M.A., & Olshansky, E. (1998). Becoming a primary care nurse practitioner: Challenges of the initial year of practice. Nurse Practitioner, 23(7), 46, 52–56, 58.

8 Brykcznski, K.A. (2019). Role development of the advanced practice nurse. In M.F. Tracy & E.T. O’Grady (Eds), Hamric and Hanson’s advanced practice nursing: an integrative approach (6th ed., pp. 80–108). St. Louis, MO: Saunders Elsevier Health Sciences.

9 Code of Colorado Regulations. (2017). Board of nursing. 3CCR 716‐1. (1.15) rules and regulations for prescriptive authority for advanced practice registered nurses. Retrieved from https://www.sos.state.co.us/CCR/GenerateRulePdf.do?ruleVersionId=9035&fileName=3%20CCR%20716‐1. (Accessed 2 November 2020.)

10 Commonwealth Fund. (2019). Pharmacy benefit managers and their role ion drug spending. Retrieved from https://www.commonwealthfund.org/publications/explainer/2019/apr/pharmacy‐benefit‐managers‐and‐their‐role‐drug‐spending. (Accessed 7 September 2020.)

11 Congressional Budget Office. (1979). Physician extenders: Their current and future role in medical care delivery. Washington, DC: US Government Printing Office.

12 DeFrank, J.T., Berkman, N.D., Kahwathi, L., et al. (2019). Direct‐to‐consumer advertising of prescription drugs and the patient–prescriber encounter: A systematic review. Health Communication, 35(6), 739–146.

13 DesRoches, C.M., Clarke, S., Perloff, J., et al. (2017). The quality of primary care provided by nurse practitioners to vulnerable Medicare beneficiaries. Nursing Outlook, 65(6), 679–688.

14 Dulisse, B., & Cromwell, J. (2010). No harm found when nurse anesthetists work without supervision by physicians. Health Affairs, 29(8), 1469–1475.

15 Dunphy, L.M. (2018). Advanced practice nursing: Doing what has to be done. In L. Joel (Ed.), Advanced practice nursing: Essentials for role development (pp. 2–16). Philadelphia: F.A. Davis.

16 Farrell, V.M., Hill, V.L., Hawkins, J.B., et al. (2003). Clinic for identifying and addressing polypharmacy. American Journal of Health‐System Pharmacy, 60(18), 1834–1835.

17 Fick, D.M., Cooper, J.W., Wade, W.E., et al. (2003). Updating the Beers Criteria for potentially inappropriate medication use in older adults: Results of a US consensus panel of experts. Archives of Internal Medicine, 163(22), 2716–2724.

18 Filipova, A. (2019). Relationship of direct‐to‐consumer advertising to efficiency of care, quality of care and health outcomes. Journal for Healthcare Quality, 42(3), e18–e31.

19 Fletcher, C.E., Baker, S.J., Copeland, L.A., et al. (2007). Nurse practitioners’ and physicians’ views of NPs as providers of primary care to veterans. Journal of Nursing Scholarship, 39(4), 358–362.

20 Fulton, M.M., & Allen, E.R. (2005). Polypharmacy in the elderly: A literature review. Journal of the American Academy of Nurse Practitioners, 17(4), 123–132.

21 Garzon Maaks, D.L., Starr, N.B., Brady, M.A., et al. (2020). Burns’ pediatric primary care (7th ed.). St. Louis, MO: Elsevier.

22 Grace, P.J. (2009). Nursing ethics and professional responsibility in advanced practice. Sudbury, MA: Jones & Bartlett.

23 Horrocks, S., Anderson, E., & Salisbury, C. (2002). Systematic review of whether nurse practitioners working in primary care can provide equivalent care to doctors. British Medical Journal, 324(7341), 819–823.

24 Jennings, N., Clifford, S., Fox, A.R., et al. (2015). The impact of nurse practitioner services on cost, quality of care, satisfaction and waiting times in the emergency department: A systematic review. International Journal of Nursing Studies 52(1), 421–435.

25 Jones, L.K., Ladd, I.G., Gregor, C., et al. (2019). Understanding the medication prior‐authorization process: A case study of patients and clinical staff from a large rural integrated health delivery system. American Journal of Health Systems Pharmacy, 76(7), 453–459.

26 Kaplan, L., & Brown, M.A. (2004). Prescriptive authority and barriers to NP practice. The Nurse Practitioner, 29(3), 28–35.

27 Kaplan, L., & Brown, M.A. (2006). What is “true” professional autonomy? Nurse Practitioner, 31(3), 37.

28 Kraus, E., & DuBois, J.M. (2017). Knowing your limits: A qualitative study of physician and nurse practitioner perspectives of NP independence in primary care. Journal of General Internal Medicine, 32(3), 284–290.

29 Landsperger, J.S., Semler, M.W., Wang, L., et al. (2016). Outcomes of nurse practitioner‐delivered critical care: A prospective cohort study. Chest, 149(5), 1146–1154.

30 Laurant, M., van der Biezen, M., Wijers, N., et al. (2018). Nurses as substitutes for doctors in primary care. Cochrane Database Systematic Reviews, 7(7), CD001271.

31 Lenz, E.R., Mundinger, M.O., Kane, R.L., et al. (2004). Primary care outcomes in patients treated by nurse practitioners or physicians: two year follow up. Medical Care Research and Review, 51(3), 332–351.

32 Lowry, J.A., & Leeder, J.S. (2015). Over‐the‐counter medications: Update on cough and cold preparations. Pediatrics in Review, 36(7), 286–298.

33 McVeigh, D.M. (2001). Polypharmacy in the older population: Recommendations for improved clinical practice. Topics in Emergency Medicine, 23(3), 68–75.

34 National Council of State Boards of Nursing. (2020). Member board profiles. Retrieved from https://www.ncsbn.org/profiles.htm. (Accessed 7 September 2020.)

35 National Conference of State Legislatures. (2020). State medical marijuana laws. Retrieved from http://www.ncsl.org/research/health/state‐medical‐marijuana‐laws.aspx. (Accessed 7 September 2020.)

36 Newhouse, R.P., Stanik‐Hutt, J., White, K.M., et al. (2011). Advance practice nurse outcomes 1990–2008: A systematic review. Nursing Economics, 29(5), 1–22.

37 Ohman‐Strickland, P.A., Orzano, A.J., Hudson, S.V., et al. (2008). Quality of diabetes care in family medicine practices: Influence of nurse practitioners and physician’s assistants. Annals of Family Medicine, 6(1), 14–22.

38 O’Keefe, M.E. (2001). Nursing practice and the law. Philadelphia: F.A. Davis Company.

39 Phillips, S.J. (2007). A comprehensive look at the legislative issues affecting advanced nursing practice. The Nurse Practitioner, 32(1), 14–17.

40 Prescott, P.A., & Driscoll, L. (1980). Evaluating nurse practitioner performance. Nurse Practitioner, 1(1), 28–32.

41 Safriet, B.J. (1992). Health care dollars and regulatory sense: The role of advanced practice nursing. Yale Journal on Regulation, 9(2), 417–488.

42 Safriet, B.J. (2002). Closing the gap between can and may in healthcare provider’s scopes of practice: A primer for policymakers. Yale Journal on Regulation, 19(2), 301–334.